365bet娱乐

Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.

Product Details:      

Name: Bortezomib

Synonyms: 

Radiciol;

Bortezomib Base;

Bortezmib;

VELCADE;

MG-341 PS-341;

CAS: 179324-69-7

EINECS: 605-854-3

MF: C19H25BN4O4

MW: 384.23700

MP: 122-124°颁

BP: N/A

FP: N/A

Purity: 95%min

Density: 1.214

Refractive index: 1.564

Appearance: yellow solid

Stability: Hygroscopic and Moisture Sensitive

Package: 5g, 25g, 100g, 500g, 1kg, 25kg

Storage Condition: Hygroscopic, -20°C Freezer, Under Inert Atmosphere

Application: inhibitor

Hot Tags: bortezomib cas: 179324-69-7, China, manufacturers, in stock, free sample, high quality, low price, 2 phenylacetamide, Triphenylene 2 3 6 7 10 11 hexaol , CAS No 1771 18 2, 3 4 Fluorophenyl 1 isopropyl 1H indole, CAS No 289042 12 2, CAS No 497 25 6